A Markov model unveiling the impact of Resmetirom on the natural history of MASLD patients with baseline significant or severe liver fibrosis

Saved in:
Bibliographic Details
Published in:Digestive and liver disease 2024-02, Vol.56, p.S14
Main Authors: Pennisi, G., Maria, G. Di, Celsa, C., Enea, M., Vaccaro, M., Ciccioli, C., Infantino, G., Tulone, A., Marco, V. Di, Cammà, C., Petta, S.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1590-8658
DOI:10.1016/j.dld.2024.01.023